This course has expired. View available courses.
Endocrinology
The next step in the management of type 2 diabetes – QI&CPD – Category 2
Optimisation of blood glucose management is important for all patients with type 2 diabetes to improve both short-term and long-term health outcomes. General glycaemic targets have therefore been set for newly-diagnosed patients with uncomplicated diabetes at an HbA1c = 7% (53mmol/mol). Despite these guidelines for glycaemic management, however, over 60% of patients are reported as not reaching their glycaemic goals. One Australian study showed less than half of all patients with type 2 diabetes seen in general practice had an HbA1c = 7% (53 mmol/mol) while 25% had an HbA1c > 8% (64mmol/mol).
DURATION
2 hrs
PROFESSION
Physician
# OF CREDITS
4
ACCREDITATION
QI & CPD - Category 2
EXPIRY DATE
2020-06-29
Optimisation of blood glucose management is important for all patients with type 2 diabetes to improve both short-term and long-term health outcomes. General glycaemic targets have therefore been set for newly-diagnosed patients with uncomplicated diabetes at an HbA1c = 7% (53mmol/mol). Despite these guidelines for glycaemic management, however, over 60% of patients are reported as not reaching their glycaemic goals. One Australian study showed less than half of all patients with type 2 diabetes seen in general practice had an HbA1c = 7% (53 mmol/mol) while 25% had an HbA1c > 8% (64mmol/mol).
Faculty
Associate Professor Michael d'Emden
MBBS, PhD, FRACP
Director of Endocrinology and Diabetes
Royal Brisbane Hospital
Queensland, Australia
Damian Flanagan
MBBS, MWell, DipRACOG
South Coast Medical
Blairgowrie, Victoria, Australia